Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 19, 2025 • 5:30 AM ET

Date/Time Source News Release
06/17/2025 07:30 AM EDT Business Wire Agenus and Noetik Enter Collaboration to Develop AI-Enabled Predictive Biomarkers for BOT/BAL Using Foundation Models of Virtual Cell Biology
06/10/2025 01:30 PM EDT Business Wire Agenus Announces Virtual Annual Shareholders Meeting
06/03/2025 07:00 AM EDT Business Wire Agenus and Zydus Lifesciences Enter $141M Strategic Collaboration to Advance BOT/BAL, Expand Zydus' Biologics Manufacturing in the US
05/30/2025 07:30 AM EDT Business Wire Agenus Presents New Data at ASCO Highlighting Botensilimab's Immune Activation in MSS Colorectal Cancer
05/15/2025 10:40 AM EDT Business Wire Agenus Announces New Data from Expanded MSS Metastatic Colorectal Cancer Cohort to be Presented at ESMO GI 2025
05/12/2025 07:30 AM EDT Business Wire Agenus Reports Q1 2025 Financial Results and Key Business Updates
05/12/2025 07:20 AM EDT Business Wire Renowned GI Oncology Leader Dr. Richard Goldberg Joins Agenus as Chief Development Officer
04/29/2025 07:30 AM EDT Business Wire Agenus to Provide Corporate Update and First Quarter 2025 Financial Report
04/28/2025 03:30 PM EDT Business Wire Agenus' BOT/BAL Neoadjuvant Pan-Cancer Data from the NEOASIS Study Presented in an Oral Session at AACR
04/25/2025 01:05 PM EDT Business Wire Agenus' BOT/BAL Data in Pretreated Liver Cancer Presented at AACR 2025
Page